References
Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation 2007; 84: 814–820.
Gebremedhin E, Behrendt CE, Nakamura R, Parker P, Salehian B . Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease. Inflammation 2013; 36: 177–185.
Fuji S, Kim SW, Mori S, Kamiya S, Yoshimura K, Yokoyama H et al. Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study. Bone Marrow Transplant 2009; 44: 105–111.
Scurlock C, Raikhelkar J, Mechanick JI . Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)—a review of recent literature. Curr Opin Clin Nutr Metab Care 2010; 13: 211–214.
van Hooff JP, Christiaans MH, van Duijnhoven EM . Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 2004; 19: vi8–vi12.
Wallace TM, Levy JC, Matthews DR . Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487–1495.
Jeschke MG, Kulp GA, Kraft R, Finnerty CC, Mlcak R, Lee JO et al. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med 2010; 182: 351–359.
Saberi F, Heyland D, Lam M, Rapson D, Jeejeebhoy K . Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr 2008; 32: 227–235.
Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452–458.
Losser MR, Damoisel C, Payen D . Bench-to-bedside review: glucose and stress conditions in the intensive care unit. Crit Care 2010; 14: 231.
Remberger M, Sundberg B . Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantation. Haematologica 2004; 89: 710–716.
Andersen J, Heilmann C, Jacobsen N, Nielsen C, Bendtzen K, Muller K . Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 635–640.
Chambrier C, Laville M, Rhzioual Berrada K, Odeon M, Bouletreau P, Beylot M . Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) 2000; 99: 321–328.
Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y et al. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 510–517.
Fuji S, Kim SW, Mori S, Furuta K, Tanosaki R, Heike Y et al. Decreased insulin secretion in patients receiving tacrolimus as GVHD prophylaxis after allogeneic hematopoietic SCT. Bone Marrow Transplant 2010; 45: 405–406.
Acknowledgements
We thank the medical, nursing, data processing, laboratory and clinical staff at the National Cancer Center Hospital for their important contributions to this study and their dedicated care of the patients. This study was supported in part by grants from the Ministry of Health, Labour and Welfare of Japan. SF designed the research study, performed the research, analyzed the data and wrote the paper. KY, S-WK, KS and TF designed the research study, and performed the research. KY analyzed the data. All authors approved the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Fuji, S., Yakushijin, K., Kim, SW. et al. Dynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50, 1473–1475 (2015). https://doi.org/10.1038/bmt.2015.163
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.163
- Springer Nature Limited
This article is cited by
-
Hyperglycemia as a possible risk factor for mold infections—the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2017)
-
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT
Bone Marrow Transplantation (2016)